Integrin Beta 3 Market is estimated to be US$ XX million by 2030 with a CAGR of XX% during the forecast period

Download Sample

Published Date: June 2023

The Integrin Beta 3 Market accounted for US$ XX million in 2020 and is estimated to be US$ XX million by 2030 and is anticipated to register a CAGR of XX%. Integrin beta-3 or CD 61 is a protein that encode by ITGB3 gene in humans which are cluster of differentiation found on thrombocytes. Integrin beta 3 is found along with alpha IIb chain in platelets and are receptors for cytotactin, laminin, matrix, osteopontin, prothrombin, vitronectin, von willebrand factor and others. Platelet interact through binding of soluble fibrinogen when integrin alpha-IIb/beta-3 and leads to rapid platelet aggregation which physically plugs ruptured endothelial surface.

The report " Global Integrin Beta3 Market, By Type (MSP-68, OCU-200, AC-301, C-16Y and Others), By Indication (Melanoma, Lung Cancer, Arterial Thrombosis and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Highlights:

On 16^th Jan 2020, Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced that U.S. Food and Drug Administration (FDA) granted fast track designation for APD418, a Beta-3 adrenergic receptor (AdrR) anatogonist and cardiac myotrope, for the development of treatment of decompensated heart failure (DHF).
On 13^th Aug 2019, Schrödinger (NASDAQ: SDGR) announced an expansion of its computational design collaboration with Morphic Therapeutic (NASDAQ: MORF), a biotechnology company focused on developing a new class of oral small-molecule integrin-targeted therapeutics.
Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) pipeline Target constitutes close to 24 molecules. Out of which approximately 19 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase II, Phase I, IND/CTA Filed and Preclinical stages are 2, 1, 1 and 15 respectively. Similarly, the universities portfolio in Preclinical stages comprises 5 molecules, respectively.

Analyst View:

Increasing incidence of lung cancers is the major growth driver of global integrin beta-3 market. Many key players are coming with new drugs and new technologies like Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) pipeline Target constitutes close to 24 molecules. Various organizations such as W.H.O., FEAT, and others along with the government are spreading awareness about this syndrome condition which is anticipated to facilitate market growth in the forecast period.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Integrin Beta3 Market, By Type (MSP-68, OCU-200, AC-301, C-16Y and Others), By Indication (Melanoma, Lung Cancer, Arterial Thrombosis and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Market Insights from the report:

The Global Integrin Beta 3 Market accounted for US$ XX million in 2020 and is estimated to be US$ XX million by 2029 and is anticipated to register a CAGR of XX%. The Global Integrin Beta 3 Market is segmented based on the type, indication, distribution channel, and region.

By Type, the Global Integrin Beta 3 Market is segmented into MSP-68, OCU-200, AC-301, C-16Y and Others.
By Indication, the market is segmented in Melanoma, Lung Cancer, Arterial Thrombosis and Others.
By Distribution Chanel, the Global Integrin Beta 3 Market is segmented into Hospital Pharmacies, Online Pharmacies and Others.
By region, the Global Integrin Beta 3 Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the worldwide leader in the integrin beta 3 market in terms of revenue, due to the developed healthcare system and health awareness among people.

Competitive Landscape:

The key players operating in the Global Integrin Beta 3 Market include Factor Therapeutics Ltd (FTT:ASE), Merck & Co Inc (NYSE: MRK), SciFluor Life Sciences LLC, SOM Biotech SL, Vascular Pharmaceuticals Inc (VBLT) and VDDI Pharmaceuticals.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period